BerGenBio ASA (LTS:0RU5) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 20, 2025)

View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

BerGenBio ASA (LTS:0RU5) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

BerGenBio ASA Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (LTS:0RU5) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

BGBIO:Norway 7BG0:Germany

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.

BerGenBio ASA Headlines

No Headlines